Descriptive analysis of patients with ovarian clear cell carcinoma recurrence
| n=61 | |
| Median age at diagnosis (range) | 58 (51, 66) |
| Stage at initial diagnosis | |
| Early: | 43 (70.5%) |
| Stage I | 35 (57.4%) |
| Stage II | 8 (13.1%) |
| Advanced: | 18 (29.5%) |
| Stage III | 15 (24.6%) |
| Stage IV | 3 (4.9%) |
| Lymph node dissection | |
| No | 43 (70.5%) |
| Yes | 18 (29.5%) |
| Lymph node staging status | |
| Full surgical staging | 13 (21.3%) |
| Partial surgical staging | 5 (8.2%) |
| Cytology status | |
| Negative | 4 (6.6%) |
| Positive | 15 (24.6%) |
| Initial surgical outcome | |
| No visible residual disease | 56 (91.8%) |
| Residual disease <1 cm | 2 (3.3%) |
| Residual disease ≥1 cm | 3 (4.9%) |
| Adjuvant chemotherapy | |
| No | 17 (27.9%) |
| Yes | 44 (72.1%) |
| Adjuvant radiation | |
| No | 46 (75.4%) |
| Yes | 15 (24.6%) |